Halliburton heads into its third-quarter report with an unusual mismatch between narrative and price. Three months ago, management sounded more confident than it had in a year, pointing to a string of international contract wins and an early North American recovery. Since then the stock has drifted lower while the broader market climbed. The October 20 report, due before the open, is the first real test of whether that optimism can show up in margins even while the top line takes a planned step back.
The Street expects earnings of $0.58 per share on revenue of about $5.59 billion. Both figures are essentially flat against the year-ago quarter, and revenue would be down roughly 2% from the $5.71 billion posted last quarter. That sequential dip is not a surprise. Management guided Completion and Production revenue flat to down 2% and Drilling and Evaluation down 3% to 5%, citing rig moves, programs rolling off and the sale of the chemicals business. The more interesting part of the guide is margins: Completion and Production was expected to expand by 125 to 175 basis points and Drilling and Evaluation by 25 to 75 basis points. Consensus EPS climbing from last quarter's $0.55 to $0.58 on lower sales effectively assumes management delivers on that margin call. Revenue near the forecast with a miss on profitability would undercut the core of the bullish case.
The drivers behind those margins deserve close scrutiny. In North America, revenue rose 7% sequentially last quarter as idle capacity was put back to work and pricing improved modestly. Management framed pricing gains as a gradual climb rather than a sudden jump, so evidence that fleets stayed busy and pricing held or inched higher would support the recovery story. Internationally, management raised its growth outlook outside the Middle East to low double digits, and Europe-Africa jumped 19% sequentially. The catch is that new work in Iraq, Saudi Arabia's Jafura field, Algeria, Suriname and Argentina carries mobilization and start-up costs that management did not quantify. Commentary on how quickly those contracts reach full run rate, particularly the first Zeus fleet heading toward a fourth-quarter start for YPF, will shape views of 2027, when management has suggested incremental margins could be above normal.
The Middle East remains the wild card. Conflict disruptions in Iraq, Kuwait and Qatar trimmed Middle East-Asia revenue last quarter after weighing on results earlier in the year. Guidance assumed steady activity with neither a rebound nor fresh disruption, which leaves some room for upside if conditions settled but real risk if escalations caused more of the start-then-stop pattern management described. Cash flow is another checkpoint. Free cash flow rebounded to $668 million last quarter, and management signaled buybacks would rise from the roughly $200 million quarterly pace. Following through on that would reinforce confidence in the outlook.
Sentiment has soured noticeably, with bearish readings more than doubling from the prior quarter. The stock is down 2.3% since the last report, trailing the S&P 500 by nearly 7 points, and at $32.55 it trades below its 200-day moving average of $35.51 and near the bottom of its post-earnings range of $30.98 to $38.06. That range sits well below the prior quarter's, a sign the market has been steadily discounting the turnaround. Lowered enthusiasm can make a clean quarter more impactful, though a stock near its lows can also react sharply to disappointment.
The central question is whether margin expansion arrives on schedule despite softer revenue and start-up costs. If it does, and international ramps look on track, the improving narrative from last quarter stays intact and the stock's underperformance starts to look excessive. If it does not, the growth story risks being pushed out another year.